Skip to content

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health

DAILYZ HEALTH NEWS

ALL ABOUT DAILYZ HEALTH NEWS

  • Home
  • Infectious Disease
  • Metabolic
  • Neurological
  • Nutrition
  • Public Health
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
Measles cases top 5,000
Health

Measles Cases Top 5,000 in U.S. for First Time in 35 Years as Death Toll Rises

November 9, 2026 Evan Vega

CDC reports 5,182 measles cases in US, highest since 1991, with 8 deaths; 96% of cases among unvaccinated or unknown status.

Lp(a) reduction, neutral outcome
Health

Lp(a) HORIZON Trial: Lp(a) Fell by 78%, but Cardiovascular Outcomes Unexpectedly Neutral

November 8, 2026 Evan Vega
Infant bleeding episodes jump
Health

U.S. Infant Bleeding Episodes Jump as Vitamin K Refusals Rise, Two Studies Find

November 8, 2026 Evan Vega
Amivantamab approved for HNSCC
Health

FDA Grants Accelerated Approval to Amivantamab and Hyaluronidase for Previously Treated HNSCC

November 7, 2026 Evan Vega
FDA approves Rybrevant Faspro
Health

FDA Approves Rybrevant Faspro for Advanced Head and Neck Cancer

November 7, 2026 Evan Vega
Health
July 14, 2026 Evan Vega

Cyclosporiasis Cases Surpass 3,000 as Michigan Identifies Lettuce and Salad Greens as Potential Source

Michigan reports over 3,000 cyclosporiasis cases linked to lettuce and salad greens in southeast counties as of July 13, 2026.

Read More
Health
July 14, 2026 Evan Vega

Lupin recalls more than 2.5 million prescription eye drop bottles, citing possible contamination

Lupin Pharmaceuticals recalled over 2.5 million bottles of Prednisolone Acetate eye drops in the U.S. due to potential contamination concerns.

Read More
Health
July 14, 2026 Evan Vega

More Than 2 Million Bottles of Eye Drops Recalled Over Potential Contamination

The FDA recalled over 2 million bottles of OTC eye drops nationwide due to potential contamination risking eye infections and vision loss.

Read More
Health
July 12, 2026 Evan Vega

Wyoming Department of Health Confirms Third Measles Case of 2026 in Unvaccinated Adult

Wyoming reports third 2026 measles case in an unvaccinated adult in Teton County, underscoring the disease’s contagious risk.

Read More
Health
July 12, 2026 Evan Vega

FDA Approves Isatuximab On-Body Injector for Multiple Myeloma, Raising Anti-CD38 Competition

The FDA approved Sarclisa Escena, an on-body injector delivering isatuximab for multiple myeloma treatment, marking a first in anticancer therapy delivery.

Read More
Health
July 10, 2026 Evan Vega

Healthcare ransomware attacks remain resilient in H1 2026 as extortion groups broaden supply chain attacks

Healthcare ransomware attacks surged in H1 2026 as extortion groups expanded tactics to include supply chain attacks, targeting the sector heavily.

Read More
Health
July 10, 2026 Evan Vega

IKS Health acquires TruBridge in $557 million deal

IKS Health will acquire TruBridge for $557 million in cash, including $427 million equity and $130 million debt, with earnings accretion expected by 2027.

Read More
Health
July 10, 2026 Evan Vega

Lupin Pharmaceuticals recalls 2.5 million bottles of prescription steroid eye drops over contamination

Lupin Pharmaceuticals recalled over 2.5 million steroid eye drop bottles in the U.S. due to contamination with foreign particles, FDA reports.

Read More
Health
July 9, 2026 Evan Vega

Study shows new once-daily weight-loss pill orforglipron outperforms leading oral semaglutide in patients with type 2 diabetes on weight and A1C reduction

Eli Lilly’s once-daily orforglipron showed greater A1C and weight reduction than oral semaglutide in a 52-week type 2 diabetes trial.

Read More
Health
July 6, 2026 Evan Vega

FDA clears first software as a medical device with a patient-facing large language model

UpDoc received FDA 510(k) clearance for UpDoc V1.0, the first patient-facing large language model software for managing type 2 diabetes.

Read More
  • ← Previous
  • Next →
Copyright © 2026 DAILYZ HEALTH NEWS. Powered by ColorMag and WordPress.